MX2015007571A - Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes. - Google Patents

Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes.

Info

Publication number
MX2015007571A
MX2015007571A MX2015007571A MX2015007571A MX2015007571A MX 2015007571 A MX2015007571 A MX 2015007571A MX 2015007571 A MX2015007571 A MX 2015007571A MX 2015007571 A MX2015007571 A MX 2015007571A MX 2015007571 A MX2015007571 A MX 2015007571A
Authority
MX
Mexico
Prior art keywords
preparation
dosage forms
solid dosage
high content
sodium ibuprofen
Prior art date
Application number
MX2015007571A
Other languages
English (en)
Inventor
Latria N Boudoin
Gregory H Lambeth
Eric W Liimatta
Patrick C Hu
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015007571(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of MX2015007571A publication Critical patent/MX2015007571A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe un método para la preparación de tabletas que se pueden tragar fácilmente, dosificadas de manera fiable, estéticamente mejoradas de dihidrato de ibuprofeno sódico, el método comprende la formación de las tabletas con punzones o prensas que comprende superficies de contacto de cromo o cromadas.
MX2015007571A 2012-12-14 2013-12-04 Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes. MX2015007571A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (1)

Publication Number Publication Date
MX2015007571A true MX2015007571A (es) 2016-04-15

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007571A MX2015007571A (es) 2012-12-14 2013-12-04 Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes.

Country Status (9)

Country Link
EP (1) EP2931261A1 (es)
JP (1) JP6285952B2 (es)
CN (1) CN104884048B (es)
BR (1) BR112015013945A8 (es)
CA (1) CA2894272A1 (es)
CL (1) CL2015001621A1 (es)
HK (1) HK1210591A1 (es)
MX (1) MX2015007571A (es)
WO (1) WO2014093073A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043614A1 (en) 2017-08-31 2019-03-07 Novartis Ag PROCESS FOR THE PREPARATION OF GRANULES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20120076865A1 (en) * 2010-03-24 2012-03-29 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

Also Published As

Publication number Publication date
HK1210591A1 (en) 2016-04-29
EP2931261A1 (en) 2015-10-21
CN104884048A (zh) 2015-09-02
JP2016508124A (ja) 2016-03-17
BR112015013945A2 (pt) 2017-07-11
CA2894272A1 (en) 2014-06-19
CL2015001621A1 (es) 2015-08-07
CN104884048B (zh) 2018-11-23
BR112015013945A8 (pt) 2019-10-08
WO2014093073A1 (en) 2014-06-19
JP6285952B2 (ja) 2018-02-28

Similar Documents

Publication Publication Date Title
TW201711676A (en) Ferric citrate dosage forms
PT3013571T (pt) Método para a produção contínua de comprimidos, sistema de formação de comprimidos para a execução do método e utilização do sistema de formação de comprimidos para a produção de comprimidos de, pelo menos, dois ingredientes que contenham partículas com uma diferença significativa no tamanho das partículas
CA140754S (en) Tablet
MX348470B (es) Pirimidinas anilladas sustituidas y uso de las mismas.
PH12014502496A1 (en) Bicyclically substituted uracils and the use thereof
EP2832350A4 (en) PROCESS FOR PRODUCING DELIBERATE PARTICLE COMPOSITION COMPRISING ACIDIC TYPE CARBOXYMETHYLCELLULOSE, COMPOSITION OF DELITING PARTICLES COMPRISING ACIDIC TYPE CARBOXYMETHYLCELLULOSE, AND ORAL DISSOLUTION COMPRESSING CONTAINING DELIBERATIVE PARTICLE COMPOSITION COMPRISING CARBOXYMETHYLCELLULOSE OF ACID TYPE
MX367210B (es) Soluciones orales estables para api combinados.
IN2014DN06966A (es)
MX2013006860A (es) Tableta soluble a base de leche con la superficie tratada con carbohidrato.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
MX2016001303A (es) Composiciones farmaceuticas de ranolazina y dronedarona.
IL235293A (en) A method for producing starch granules and a crumbling tablet in the mouth
IN2013MU01111A (es)
MX2015007571A (es) Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes.
ZA201504280B (en) Medicinal lozenge based on ibuprofen sodium dihydrate
EP3024326A4 (en) Novel process for the preparation of levothyroxine sodium
TR201103625A1 (tr) Sefuroksim içeren tablet formülasyonu üretim prosesi.
PH12015500469A1 (en) High dose extended-release potassium citrate wax matrix tablet
EP3050575A4 (en) Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
WO2013083226A8 (de) Porenarmes, wasserfreies natriumcarbonat
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
IN2014MU00665A (es)
TN2014000085A1 (en) Substituted annellated pyrimidine and the use thereof
UA48018U (en) pill machine
UA74050U (ru) Способ оценки функции глотания при нейрогенной дисфагии в острый период мозгового инсульта